Donald Trump & Pfizer
17 shared events · Importance 4 · Last updated Sep 18, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Donald Trump: President Trump announced the new drug pricing deals, taking credit for declining drug prices. The agreements bolster his administration's healthcare affordability agenda ahead of midterm elections.
Pfizer: Pfizer was among the earlier 17 drugmakers that signed MFN deals, setting a precedent. The new agreements expand the framework to more companies.
Aug 18, 2026 · 37 articles
Regulatory
Donald Trump: The President could weigh in on the draft rules, which remain subject to change, and is due to meet Xi Jinping next week.
Pfizer: Pfizer has lobbied against broad restrictions and announced an up to $10.5 billion collaboration with Innovent Biologics covering 12 oncology programs.
Sep 18, 2026 · 6 articles
Domestic
Donald Trump: His administration's rollback of vaccine recommendations created confusion, prompting medical groups to step in.
Pfizer: Offers COVID-19 vaccines; benefits from continued recommendations and potential increased uptake.
Sep 02, 2026 · 20 articles
Regulatory
Donald Trump: Donald Trump initiated the United States — Medicaid pilot program and other initiatives aimed at reducing U.S. prescription drug prices.
Pfizer: Pfizer previously signed a deal with the administration regarding drug pricing and co-developed Xtandi with Astellas Pharma.
Apr 20, 2026 · 6 articles
Business
Donald Trump: Held off on strikes against Iran, easing oil prices. Pushed for lower rates.
Pfizer: Reported upbeat quarterly results, leading to a stock gain.
Jul 14, 2026 · 280 articles
Domestic
Donald Trump: Beneficiary of the controversy as it undermines his predecessor's administration.
Pfizer: Mentioned as vaccine manufacturer; no direct impact from diary release.
Jul 29, 2026 · 13 articles
Business
Donald Trump: Donald Trump's administration has prioritized domestic investment, and AstraZeneca has already committed $50 billion to US manufacturing. The merger would likely need approval from his antitrust authorities.
Pfizer: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
Regulatory
Donald Trump: As President, Trump's administration has overseen vaccine policy changes and FDA leadership, influencing the regulatory climate.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Domestic
Donald Trump: Signed an executive order on childhood vaccines; his administration is not directly involved in the Fauci texts but is part of the political backdrop.
Pfizer: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
Tech
Donald Trump: The Trump administration has been critical of mRNA technology, and its policies could affect regulatory approval and public acceptance of the vaccine. However, the trial's success may temper some opposition.
Pfizer: Pfizer, a partner of BioNTech, may benefit indirectly from the validation of mRNA technology in cancer treatment.
Aug 19, 2026 · 126 articles
Regulatory
Donald Trump: President Trump has promoted AI advancement as crucial to economic and national security, but is not directly involved in eminent domain disputes.
Pfizer: Pfizer facility was the intended beneficiary of the Kelo seizure, but the company later left New London.
Jul 16, 2026 · 6 articles
Accidents
Donald Trump: Donald Trump's administration has been criticized for withdrawing from the World Health Organization and restricting United States — Centers for Disease Control and Prevention scientists, contributing to the agency's diminished capacity.
Pfizer: Pfizer is mentioned in false conspiracy theories linking its vaccine to the Hantavirus outbreak, which health officials are working to counter.
May 07, 2026 · 368 articles
Regulatory
Donald Trump: Donald Trump, US President, was a subject of discussion in the 'Washington Group' chat, which was reportedly set up to exchange messages when he did 'something wild and potentially damaging'.
Pfizer: Pfizer was mentioned in the context of a previous transparency dispute involving Ursula von der Leyen's text messages with its CEO, Albert Bourla, regarding COVID-19 vaccine contracts.
Jun 24, 2026 · 6 articles
Regulatory
Pfizer: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Donald Trump and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard